Table 3.
Logistic regression examining previous Myocardial Infarction* vs. no MI among primary prevention participants.
| All primary prevention participants | ||
|---|---|---|
| Parameters | OR | P value |
| Female | 0.80 | 0.04 |
| Age (years) | 1.01 | 0.38 |
| Race/Ethnicity | ||
| -White | -- | 0.02 |
| -Spanish, Hispanic, Latino | 0.94 | |
| -Black (American/Canadian) | 0.80 | |
| -Asian | 1.41 | |
| -other | 0.66 | |
| Education | ||
| -Less than high school | -- | 0.45 |
| -High school graduate | 1.13 | |
| -Some college | 1.07 | |
| -College degree or higher | 0.85 | |
| Duration of DM (years) | 0.99 | 0.61 |
| Left Ventricular Hypertrophy on baseline ECG | 1.53 | 0.06 |
| Hypertension | ||
| -Systolic (mmHg) | 1.01 | 0.07 |
| -Diastolic (mmHg) | 1.00 | 0.72 |
| Hyperlipidemia | ||
| -Total Cholesterol (mg/dL) | 1.00 | 0.84 |
| -Low-density lipoprotein (mg/dL) | 1.00 | 0.85 |
| -High-density lipoprotein (mg/dL) | 1.00 | 0.91 |
| -Triglyceride (mg/dL) | 1.00 | 0.70 |
| A1c | 1.09 | 0.18 |
| Albumin/Creatinine ratio (mg/g) | ||
| -macroalbuminuria (≥300) | 1.27 | 0.22 |
| -microalbuminuria (>=30 and <300) | 0.96 | |
| - <30 | -- | |
| Weight (kg) | 1.00 | 0.78 |
| Waist circumference (cm) | 1.00 | 0.97 |
| Body Mass Index | 1.01 | 0.70 |
| Family h/o heart disease** | 1.07 | 0.30 |
| Current Smoker | 0.99 | 0.83 |
| Alcohol use | 1.02 | 0.81 |
| History of Amputation | 0.91 | 0.75 |
| Depression | 0.96 | 0.60 |
| Insulin | 0.96 | 0.61 |
| Number of oral glycemia medications | 0.97 | 0.72 |
| Angiotensin-converting-enzyme inhibitor | 1.03 | 0.69 |
| Aspirin | 0.97 | 0.62 |
| Beta-Blocker | 1.14 | 0.11 |
| Statin | 0.96 | 0.55 |
| Angiotensin II Receptor Blocker | 0.81 | 0.32 |
*
Myocardial Infarction (Major Q wave abnormalities or Minor Q, QS waves with major ST-T abnormalities)
**
Heart disease, heart attack, stoke (before 55 for father/brother, 65 for mother/sister)